Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
This grant funds early stage testing of pharmacologic or neuromodulatory device-based interventions aimed at treating mental disorders.
About this program
The Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders grant supports innovative research focused on developing and testing new treatments for mental health conditions. This grant is intended for researchers and institutions engaged in clinical trials that explore the efficacy of pharmacologic or device-based interventions. The goal is to advance the understanding and treatment of mental disorders through rigorous scientific investigation. Eligible applicants include academic institutions, nonprofit organizations, and other entities involved in mental health research. The grant encourages collaboration among researchers, clinicians, and industry partners to foster the development of novel therapeutic approaches. Successful applicants will be expected to conduct clinical trials that meet regulatory requirements and contribute valuable data to the field of mental health treatment.
Eligibility
Academic institutions, nonprofit organizations, and other entities involved in mental health research.